scorecardresearch
Thursday, September 11, 2025
TopicPharma sector

Topic: Pharma sector

To ease launch of generics & push clinical trials of novel therapies, govt moves to amend drug rules

Proposed amendments to New Drugs and Clinical Trial Rules will scrap test licences, cut application processing time. Move part of govt effort to establish India as hub for pharma R&D.

India ceding ground in biopharma innovation, manufacturing — AllianceBernstein’s open letter to PM

Analysts from AllianceBernstein point to four areas where India lags behind its Asian peers and underline that nation finds no mention in global healthcare innovation index.

Cheap alternatives, API imports — why Penicillin G production, set to resume after 30 yrs, declined

Production of PenG, used to treat tetanus, strep infections, syphilis, pneumonia & more, was stopped in India in 1990s after cheaper alternatives began surfacing in global market.

Indian pharma firms now liable to recall defective drugs as Modi govt notifies new norms

Under revised good manufacturing practices (GMP) norms, pharma companies will be required to assume onus for quality of drugs to ensure they do not place patients at risk.

Trade body says Indian pharma exports to hit $27 billion this fiscal, despite cough syrup deaths

India is the world's third largest maker of drugs by volume, and US sales, which account for 30% of total pharma exports, have risen by 6.2% last year.

Una’s bulk drug park is the ‘next Bhakra Nangal’. And it’s BJP’s trump card in Himachal polls

In the homes of BJP supporters, photocopies of the map of the land demarcated for the bulk drug park are doing the rounds.

Haryana firm flagged by WHO after 66 child deaths in Gambia stops making ‘contaminated’ syrups

After an inspection, the Haryana government finds 12 flaws in the manufacturing facility; ‘Action will be taken,’ says Home and Health Minister Anil Vij.

Cough syrups made by Delhi-based Maiden Pharma may be tied to 66 deaths in Gambia, says WHO

In July, alarm was raised in Gambia after several children began falling ill with kidney problems. WHO has issued an alert asking regulators to remove the company's goods from the market.

Apollo, Reliance make $6.3-billion binding offer to buy UK drugstore chain Boots

Walgreens Boots Alliance’s negotiations with Apollo and Reliance currently have the most momentum, said people in the know. Their proposal values Boots at more than £5 billion ($6.3 billion).

Ireland ‘exploring’ tie-up with DU to build bridges in higher education, research collaboration

Conor Fahy of govt agency Enterprise Ireland says such collaboration can ‘deepen FDI’. DU V-C Yogesh Singh says MoU with Irish varsities likely by end of 2022.

On Camera

Coup, conspiracy & the foreign hand—What Indian TV news channels saw in Nepal this week

‘Gen Z v/s Govt’ TV news coverage went for two days—not sure about the source of the telecast from Kathmandu since no credit was given.

What’s behind bond yields’ logic-defying spike? The market’s concern over the future

While bond yields tend to fall amid low inflation & interest rate cuts, market experts say they’ve been rising due to concerns over tax collections, fiscal deficit & potential impact of US tariffs.

‘Foreign policy rests on hard power’—from 1965 Indo-Pak war to Op Sindoor, key takeaways for India

A panel of experts moderated by ThePrint’s Editor-in-Chief Shekhar Gupta drew connections between insights of 1965 Indo-Pak War and strategic takeaways highlighted by Op Sindoor.

Punjab is fast becoming the new Northeast. And there’s a message in it for Modi

In its toughest time in decades because of floods, Punjab would’ve expected PM Modi to visit. If he has the time for a Bihar tour, why not a short visit to next-door Punjab?